慢性腎臓疾患における高密度リポタンパク質のコレステロール流出能力と抗酸化作用
PubMedで要約を見る
まとめ
この要約は機械生成です。慢性腎疾患 (CKD) の患者では,高密度脂質タンパク質コレステロール (HDL- C) レベルはHDLの機能性を反映しません. HDL機能の低下は腎臓機能の低下と尿中のタンパク質濃度の上昇と関連しています.
科学分野
- 腎臓科
- 心血管研究
- 生物化学
背景
- 慢性腎疾患 (CKD) は,脂質代謝の変化と心血管の健康障害に関連しています.
- コレステロール放出能力 (CEC) と抗酸化作用は,高密度脂質タンパク質 (HDL) の機能性の主要な指標です.
- CKDのこれらの機能を理解することは,関連するリスクを管理するために不可欠です.
研究 の 目的
- 慢性腎臓病 (CKD) の患者におけるコレステロール放出能力 (CEC) と抗酸化能力 (ORAC) の変化を調査する.
- CKD患者におけるこれらの機能的変化に関連した臨床的および腎臓損傷のパラメータを特定する.
主な方法
- 腎臓バイオプシーを受けた333人のCKD患者による遡及的横断的観察研究.
- バイオプシーで採取した血清サンプルをCECとORACの分析に用いた.
- 体質指数 (BMI),高密度リポプロテイン・コレステロール (HDL-C),血清アルブミン,尿中のタンパク質クレアチニン比率 (UPCR),推定グルメルフィルタレーション率 (eGFR) を含む臨床データを評価した.
主要な成果
- 平均CECとORACはそれぞれ0. 83±0. 15と0. 86±0. 14でした.
- HDL- Cレベルは,CECとORACの両方と有意に関連していたが,CECはORACと弱い関連を示した.
- CECとHDL-CはBMIと負の相関関係があり,女性では高かった. ORACは血清アルブミンと正の相関関係があり,UPCRと負の相関関係がある.
- 多重回帰分析では,CECはeGFR,血清アルブミン,ORACと関連していることが示された. 全球性硬化症とCECまたはORACとの間には相関関係が見つかりませんでした.
結論
- 血清のHDL- C値は,CKD患者のHDL機能の信頼できる指標ではありません.
- EGFRの減少と血清アルブミンの減少は,UPCRの増加による可能性があり,CKDにおけるHDL機能の低下と関連しています.
- これらの発見は,CKDの進行における腎機能,脂質代謝,酸化ストレスとの複雑な相互作用を強調しています.
関連する概念動画
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

